Tim Dyer has weathered many storms and has recently done it again. After Addex Therapeutics Ltd. reached critically low levels of cash in 2023, the company’s CEO found a way to generate the cash needed to feed the biotech he co-founded 22 years ago.
Addex Gets Creative To Secure Funding And Its Future
Addex Therapeutics’ Tim Dyer has seen the company through 22 years of ups and downs. He has kept the company afloat, and recently did the same by spinning out a new company.
